{
  "document": "Foundation_12",
  "Genomic Findings": [
    {
      "Name": "BRAF V600E",
      "Clinical": [
        "Dabrafenib + Trametinib",
        "Encorafenib + Binimetinib",
        "Vemurafenib + Cobimetinib",
        "Dabrafenib",
        "Vemurafenib",
        "Vemurafenib + Cobimetinib + Atezolizumab",
        "Trametinib"
      ],
      "No Clinical": ["Selumetinib"]
    },
    {
      "Name": "CDKN2A/B (p16INK4a V82fs*44 and p14ARF R96fs*44 and p14ARF R96fs*7)",
      "Clinical": [],
      "No Clinical": []
    },
    { "Name": "MLL2 D277669N", "Clinical": [], "No Clinical": [] },
    { "Name": "TERT promoter -124C>T", "Clinical": [], "No Clinical": [] }
  ],
  "Biomakers findings": [
    {
      "Name": "Microsatellite status: MS-Stable",
      "Clinical": [],
      "No Clinical": []
    },
    {
      "Name": "Tumor Mutational Burden: 0 Muts/Mb",
      "Clinical": [],
      "No Clinical": []
    }
  ]
}